Pulmonary Stents Industry

The global pulmonary stents market size is expected to reach USD 306.09 million by 2030, registering a CAGR of 4.9% from 2024 to 2030, according to a new report by Grand View Research, Inc. Increasing prevalence of respiratory diseases, such as chronic obstructive pulmonary disease (COPD) and lung cancer, is a major driving force behind the expansion of the market. According to the Global Initiative for Asthma (GINA), about 200 million people worldwide are affected by COPD, with an estimated 3.2 million deaths annually. Lung cancer, a leading public health concern in the U.S., is witnessing a rise in incidence and mortality rates, further fueling the growth of the market. These stents are employed to treat various respiratory conditions, including lung cancer.

According to projections from the American Cancer Society, it is anticipated that approximately 238,340 new cases of lung cancer were diagnosed in the United States in 2023. Most of these diagnoses are expected to be in individuals aged 65 and above, with a relatively small percentage affecting those under 45. This disease poses a significant public health threat, particularly among older adults, with an average age of diagnosis around 70 years. Notably, lung cancer ranks as the leading cause of cancer-related deaths in the U.S., contributing to one in every five cancer fatalities. Annually, more lives are lost to lung cancer than the combined total of deaths from breast, colon, and prostate cancer.

The pulmonary stents industry is experiencing notable growth due to advancements in new stent technologies, particularly in the areas of 3D-printed self-expanding stents (3DPSS), biodegradable stents (BS), and drug-eluting stents (DES). According to a study published in November 2023 by the National Center for Biotechnology Information (NCBI), these innovations offer several advantages over traditional stents, including improved patient outcomes, reduced complication rates, and enhanced quality of life.

Curious about the Pulmonary Stents Market, Download your FREE sample copy now and get a sneak peek into the latest insights and trends.

Pulmonary Stents Market Segments Highlights:

  • North America led the market with a revenue share of 43.69% in 2023. The region's advanced healthcare infrastructure, increasing awareness about respiratory health, and a growing aging population contribute to the market's dominance
  • Based on product, the balloon-expandable stents segment dominated the market with a revenue share of 53.40% in 2023. These stents are often preferred when precise placement and controlled expansion are critical
  • Based on material, the metal segment dominated the industry with a revenue share of 58.89% in 2023. The growth of Metal is propelled with bare metal, and drug-eluting stents are primarily used for narrowed arteries, most commonly in the heart's coronary arteries
  • Based on type, the tracheobronchial stents segment dominated the market with a revenue share of 72.12% in 2023. Tracheobronchial stents play a crucial role in the medical management of conditions such as tracheal or bronchial stenosis, strictures, or obstructions

Pulmonary Stents Market Report Segmentation

Grand View Research has segmented the global pulmonary stents market based on product, material, type, and region:

Pulmonary Stents Product Outlook (Revenue, USD Million, 2018 - 2030)

  • Self-expandable Stents
  • Balloon-expandable Stents

Pulmonary Stents Material Outlook (Revenue, USD Million, 2018 - 2030)

  • Metal
  • Silicon
  • Hybrid

Pulmonary Stents Type Outlook (Revenue, USD Million, 2018 - 2030)

  • Tracheobronchial Stents
  • Laryngeal Stents

Pulmonary Stents Regional Outlook (Revenue, USD Million, 2018 - 2030)

  • North America
    • US
    • Canada
  • Europe
    • UK
    • Germany
    • France
    • Italy
    • Spain
    • Sweden
    • Norway
    • Denmark
  • Asia Pacific
    • China
    • Japan
    • India
    • Australia
    • Thailand
    • South Korea
  • Latin America
    • Brazil
    • Mexico
    • Argentina
  • Middle East and Africa
    • Saudi Arabia
    • South Africa
    • UAE
    • Kuwait

Key Pulmonary Stents Company Insights

  • Bess medizintechnik GmbH
  • Boston Scientific Corporation
  • Cook Group
  • Benson Hood Laboratories Inc.
  • Efer Endoscopy
  • Endo-Flex GmbH
  • Merit Medical Systems Inc.
  • Micro-Tech (Nanjing) Co. Ltd
  • Standard Sci Tech Inc.
  • Olympus Corporation

Order a free sample PDF of the Pulmonary Stents Market Intelligence Study, published by Grand View Research.